Share
Market Research Report

HUMIRA BIOSIMILAR MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Product TypeBiosimilar Humira (Adalimumab) · and Interchangeable Biosimilar Humira
  • By IndicationRheumatoid Arthritis · Psoriasis · Crohns Disease · Ulcerative Colitis · Ankylosing Spondylitis · Juvenile Idiopathic Arthritis · and Other Autoimmune Conditions
  • By Distribution ChannelHospital Pharmacies · Retail Pharmacies · and Online Pharmacies
  • By Patient AgeAdult Patients · Pediatric Patients · and Geriatric Patients
  • By GeographyNorth America · Latin America · Europe · Asia Pacific · Middle East & Africa
  • Published In26 Mar 2026
  • Report CodeCMI5925
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Indication
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Patient Age
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Patent expiration
      • Cost savings
      • Increasing prevalence of autoimmune diseases
      • Favorable regulatory environment
    • Market Restraints
    • Market Opportunity
    • Key Highlights
    • Regulatory Scenario
    • Recent Trends
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Mergers Acquisitions, and Collaborations
  4. Global Humira Biosimilar Market, By Product Type, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Biosimilar Humira (Adalimumab)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Interchangeable Biosimilar Humira
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  5. Global Humira Biosimilar Market, By Indication, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Rheumatoid Arthritis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Psoriasis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Crohn’s disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Ulcerative Colitis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Ankylosing Spondylitis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Juvenile Idiopathic Arthritis
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Other Autoimmune Conditions
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  6. Global Humira Biosimilar Market, By Patient Age, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Adult Patients
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Pediatric Patients
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Geriatric Patients
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  7. Global Humira Biosimilar Market, By Distribution Channel, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
  8. Global Humira Biosimilar Market, By Region, 2021 - 2033, (USD Mn)

    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Region, 2022 –2033
      • Country Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Patient Age, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Mn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/ Region, 2021 - 2033, (USD Mn)
        • North Africa
        • Central Africa
        • South Africa
  9. Competitive Landscape

    • Company Profiles
      • Amgen Inc.
        • Company Highlights
        • Product Portfolio
        • Key Developments
        • Financial Performance
        • Strategies
      • Samsung Bioepis Co.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Sandoz International GmbH (Novartis AG)
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Mylan N.V.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Boehringer Ingelheim International GmbH
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Pfizer Inc.
        •  Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Fresenius Kabi AG
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Coherus BioSciences
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Biogen Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • AbbVie Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Celltrion Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Rani Therapeutics Holdings, Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Teva Pharmaceutical Industries Ltd.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Merck & Co.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Viatris Inc.
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Alvotech
        • Company Highlights
        • Product Portfolio
        • Key Highlights
        • Financial Performance
        • Strategies
      • Analysts’ Views
  10. Section

    • References
    • Research Methodology
    • About us